Asset Details
Do you wish to reserve the book?
Group A Streptococcus Meningitis, United States, 1997–2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Group A Streptococcus Meningitis, United States, 1997–2022
Do you wish to request the book?
Group A Streptococcus Meningitis, United States, 1997–2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Group A Streptococcus Meningitis, United States, 1997–2022
2026
Overview
Group A Streptococcus (GAS) causes a variety of diseases in humans but is not widely appreciated as a cause of meningitis. During 1997-2022, ten sites participating in the Active Bacterial Core Surveillance network in the United States identified GAS meningitis cases. We calculated annual incidence and case-fatality rates (CFRs) for 320 of those cases and determined antimicrobial resistance by whole-genome sequencing. Annual incidence of GAS meningitis ranged from 0.02 to 0.07 cases/100,000 persons. Children <1 year of age had the highest average annual incidence, 0.23 cases/100,000 children. GAS meningitis had a higher CFR (19.4%) than meningitis caused by group B Streptococcus, Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae. Clindamycin resistance among GAS meningitis isolates increased from 3.2% during 1997-2002 to 17.7% during 2018-2022. Clinicians should be aware that meningitis is an uncommon but severe manifestation of invasive GAS and has a higher CFR than more established meningitis etiologies.
Publisher
Centers for Disease Control and Prevention
Subject
/ Adult
/ Aged
/ Anti-Bacterial Agents - pharmacology
/ Child
/ CME
/ Female
/ Group A
/ Humans
/ Infant
/ Male
/ Meningitis, Bacterial - epidemiology
/ Meningitis, Bacterial - history
/ Meningitis, Bacterial - microbiology
/ Meningitis, United States, 1997–2022
/ Streptococcal Infections - epidemiology
/ Streptococcal Infections - history
/ Streptococcal Infections - microbiology
/ Streptococcal Infections - mortality
/ Streptococcus pyogenes - classification
/ Streptococcus pyogenes - drug effects
/ Streptococcus pyogenes - genetics
/ Streptococcus pyogenes - isolation & purification
